| 2024-11-19 | -4.27 % |
|
| 2024-11-18 | +2.12 % |
|
| 2024-11-15 | -3.75 % |
|
| 2024-11-14 | -2.44 % |
|
| 2024-11-12 | -4.05 % |
|
| 2024-11-11 | +3.53 % |
|
| 2024-11-05 | +3.11 % |
|
| 2024-11-04 | -1.37 % |
|
| 2024-11-01 | |
|
| 2024-10-31 | +2.38 % |
|
| 2024-10-30 | -1.18 % |
|
| 2024-10-29 | -0.95 % |
- Walgreens Boots Alliance (WBA) stock fell by 0.95% due to reduced institutional interest, as highlighted by Hennion & Walsh Asset Management Inc. decreasing its position by 19.1%, alongside multiple analysts lowering their price targets and ratings for the company's shares.
- The article discusses the significant rise in the stock value of Trump Media & Technology Group (TMTG), which recently surpassed Walgreens Boots Alliance (WBA), contrasting it with WBA's decline of 0.95%. Walgreens Boots Alliance's stock may be down due to broader market pressures, company-specific issues, or investor sentiment that has shifted towards companies like TMTG that are perceived to have potential for greater volatility and growth tied to political events.
- The article discusses the valuation of Donald Trump’s Truth Social, which has surpassed that of Elon Musk’s X, while mentioning that Walgreens Boots Alliance (WBA) stock fell by 0.95%. Walgreens Boots Alliance's stock decrease may be attributed to broader market trends or investor sentiment shifts rather than specific news about the company, as the context of the article primarily focuses on the surging value of Trump Media.
- The article discusses the skyrocketing valuation of Trump Media & Technology Group (TMTG), which has surpassed that of Elon Musk's X Holdings, while mentioning that Walgreens Boots Alliance (WBA) is one of the companies now valued lower than TMTG. The decline in Walgreens Boots Alliance stock, which was down 0.95%, may be attributed to broader market trends or specific company challenges not detailed in the article.
- The article discusses the significant increase in the valuation of Trump's Truth Social parent company, Trump Media & Technology Group, which is now worth more than Elon Musk's X, amid speculation about Trump's re-election chances, while also noting that Walgreens Boots Alliance's stock was down by 0.95%. The decline in Walgreens Boots Alliance's stock is not directly addressed in the article, but it could be attributed to broader market trends, operational challenges, or investor sentiment affecting the retail and healthcare sectors.
|
| 2024-10-28 | +1.94 % |
|
| 2024-10-25 | -0.86 % |
|
| 2024-10-24 | -0.11 % |
|
| 2024-10-23 | -3.91 % |
|
| 2024-10-22 | -6.89 % |
|
| 2024-10-21 | -3.15 % |
|
| 2024-10-18 | +1.22 % |
|
| 2024-10-17 | -3.7 % |
|
| 2024-10-16 | +6.24 % |
- Walgreens Boots Alliance (WBA) stock rose 6.24% following its fourth-quarter earnings announcement, which exceeded estimates and included plans to close 1,200 stores, signaling potential efforts to restructure and improve its business performance.
- Walgreens Boots Alliance (WBA) stock rose by 6.24% after the company reported a 6% increase in revenue and better-than-expected earnings per share for Q4, despite a net loss, while also announcing plans to close 1,200 drugstores. The stock's increase is attributed to beating analyst expectations, which positively influenced investor sentiment.
- Walgreens Boots Alliance (WBA) stock experienced a decline of 0.7% on Wednesday, trading at $10.35, with a significant drop in trading volume compared to its average. The increase in stock price prior, which was noted to be 6.24%, may have resulted from positive market sentiment or investor confidence despite the recent decline.
- Walgreens Boots Alliance (WBA) stock rose 6.2% after the company reported better-than-expected quarterly earnings and announced a plan to close 1,200 underperforming stores as part of its turnaround strategy.
- Walgreens Boots Alliance (WBA) stock rose 6.24% due to significant increases in institutional investment, including a notable 927.1% increase in holdings by Livforsakringsbolaget Skandia Omsesidigt, suggesting growing confidence among large investors in the company's potential.
- Walgreens Boots Alliance (WBA) stock rose 6.24% after Evercore ISI raised its price target for the company from $7.50 to $10.00, indicating a positive outlook on the pharmacy operator's performance.
|
| 2024-10-15 | +15.78 % |
- Walgreens Boots Alliance's stock surged by 15.78% following the announcement of plans to close approximately 1,200 underperforming stores over the next three years as part of a turnaround strategy to improve its struggling U.S. business and financial performance.
- Walgreens Boots Alliance (WBA) shares rose 15.8% following the company's better-than-expected sales and profits for its fiscal fourth quarter, coupled with the announcement of a turnaround plan that includes closing approximately 1,200 stores over the next three years.
- Walgreens Boots Alliance (WBA) stock rose 15.78% following the announcement of plans to close around 1,200 struggling stores over the next three years to improve financial performance after reporting a $3 billion loss, which was perceived positively by investors despite ongoing challenges in the retail and pharmacy sectors.
- Walgreens Boots Alliance (WBA) stock rose by 15.78% following the company's announcement of plans to close 1,200 stores and implement turnaround strategies in response to a $3 billion quarterly loss, aiming for future profitability and consumer benefits.
The stock increase was likely influenced by investor optimism regarding the company's restructuring efforts, despite disappointing earnings.
- Walgreens Boots Alliance (WBA) stock rose 15.78% following Johnson & Johnson's strong quarterly earnings and guidance, indicating a positive market reaction to better-than-expected performance in the pharmaceutical sector, despite WBA's announcement of shutting down 1,200 stores as part of its turnaround strategy under new leadership.
- Walgreens Boots Alliance (WBA) stock rose 15.78% after the company announced plans to close about 1,200 underperforming U.S. locations over the next three years, which is expected to improve adjusted earnings and free cash flow amid ongoing struggles in their retail and pharmacy business.
- Walgreens Boots Alliance (WBA) stock surged by 15.78% following the announcement of a plan to close about 1,200 underperforming U.S. locations to help turnaround its struggling business, which is expected to improve adjusted earnings and free cash flow.
- Walgreens Boots Alliance (WBA) stock surged 15.78% due to the company's strong earnings report and the announcement of a turnaround plan that includes closing 1,200 stores over the next three years.
- Walgreens Boots Alliance's stock surged by 15.78% following its Q4 results, which showed a 6% revenue increase and beat analyst expectations despite a significant loss in earnings per share, and the company's plan to close 1,200 drugstores while focusing on monetizing non-core assets contributed to positive market sentiment.
- Walgreens Boots Alliance (WBA) stock rose 15.78% following the company's announcement of plans to close 1,200 underperforming locations as part of a turnaround strategy aimed at streamlining operations and improving profitability in response to changing consumer behavior and rising operational challenges.
|
| 2024-10-14 | -2.28 % |
|
| 2024-10-11 | +1.99 % |
- The article discusses the recent rise in Walgreens Boots Alliance (WBA) stock by 1.99%, attributed primarily to the anticipated influx of customers to its stores due to the closure of rival Rite Aid locations, particularly in regions like Ohio where pharmacies are becoming scarce.
- Walgreens Boots Alliance, Inc. (WBA) stock rose by 1.99% last night, likely due to positive market sentiment or specific developments within the company, despite lower trading volume compared to average sessions.
- Walgreens Boots Alliance (WBA) stock rose 1.99% despite Morgan Stanley reducing its price target from $9.00 to $7.00 and maintaining an "underweight" rating, likely due to broader market trends or investor sentiment not reflected in the downgrade.
- Walgreens Boots Alliance (WBA) stock rose by 1.99% likely due to positive sentiment stemming from institutional investments and earnings reports related to its subsidiary, Cencora, Inc., which demonstrated strong revenue growth and better-than-expected earnings.
- Walgreens Boots Alliance (WBA) stock rose by 1.99% likely due to positive developments relating to its major shareholder, Cencora, Inc., which reported strong quarterly earnings exceeding estimates, resulting in increased investor confidence and optimism in the company's performance.
|
| 2024-10-10 | +1.35 % |
|
| 2024-10-09 | -1.87 % |
|
| 2024-10-07 | +1.72 % |
|
| 2024-10-04 | +0.58 % |
|
| 2024-10-03 | -0.34 % |
|
| 2024-10-02 | |
|
| 2024-10-01 | -2.9 % |
|
| 2024-09-30 | -1.1 % |
|
| 2024-09-27 | +6.34 % |
|
| 2024-09-26 | +3.27 % |
|
| 2024-09-25 | -3.28 % |
|
| 2024-09-24 | -0.35 % |
|
| 2024-09-23 | -1.72 % |
|
| 2024-09-20 | -3.01 % |
|
| 2024-09-18 | -0.55 % |
|
| 2024-09-17 | +0.44 % |
|
| 2024-09-16 | -2.06 % |
|
| 2024-09-13 | +4.19 % |
|
| 2024-09-12 | +1.14 % |
|
| 2024-09-11 | -1.58 % |
|
| 2024-09-10 | -0.34 % |
|
| 2024-09-06 | +0.34 % |
|
| 2024-09-05 | +1.04 % |
|
| 2024-09-04 | -3.57 % |
|
| 2024-09-03 | -3.03 % |
- Walgreens Boots Alliance (WBA) stock fell by 3.03% due to its struggling performance and a recent replacement in the Dow Jones Industrial Average by Amazon, highlighting ongoing challenges within the company and market pressures.
- The article discusses the significant decline in Intel's stock, which has dropped about 60% this year, leading analysts to suggest that it may be removed from the Dow Jones Industrial Average due to poor sales performance and mounting losses.
The Walgreens Boots Alliance (WBA) stock specifically was not addressed in this article; however, the general market sentiment and performance of the retail and pharmacy sectors may contribute to its fluctuations.
- Walgreens Boots Alliance (WBA) stock fell 3.03% following the announcement of a class action lawsuit alleging the company and its executives made misleading statements about its financial health, particularly regarding its pharmacy division's capabilities amid industry challenges, leading to disappointing earnings and lowered projections.
- Walgreens Boots Alliance (WBA) stock dropped 3.03% amidst concerns over its removal from the Dow Jones Industrial Average, replaced by Amazon, indicating investor apprehension about the company's market standing and performance.
- The article discusses the appointment of Gina Stuart as the new Senior Vice President of Diversity, Equity, and Inclusion at Wintrust Financial Corporation, highlighting her previous role at Walgreens Boots Alliance (WBA). The WBA stock likely declined due to market reactions to company management changes or strategic shifts, though specific reasons for the decline are not detailed in the article.
- The article discusses the potential removal of Intel from the Dow Jones Industrial Average due to a significant decline in its share price, which has dropped nearly 60% this year, compounded by poor global chip sales and strategic missteps that have negatively impacted its reputation and market performance.
Walgreens Boots Alliance (WBA) stock experienced a decline likely related to its poor performance and instability in the market, leading to its previous replacement by Amazon in the Dow, indicating ongoing challenges for the company that could affect investor confidence.
|
| 2024-08-30 | |
|
| 2024-08-14 | -1.23 % |
|
| 2024-08-13 | +3.53 % |
|
| 2024-08-12 | -4.49 % |
|
| 2024-08-08 | +0.74 % |
|
| 2024-08-07 | -1.19 % |
|
| 2024-08-05 | -6.62 % |
|
| 2024-08-01 | -0.51 % |
|
| 2024-07-31 | -2.38 % |
|
| 2024-07-25 | +3.14 % |
|
| 2024-07-23 | -0.62 % |
|
| 2024-07-22 | +2.63 % |
|
| 2024-07-19 | -3.08 % |
|
| 2024-07-18 | -4.14 % |
|
| 2024-07-17 | +1.02 % |
|
| 2024-07-16 | +0.26 % |
- The article notifies investors in Walgreens Boots Alliance, Inc. of a class action securities lawsuit seeking to recover losses due to alleged securities fraud, leading to a drop in stock price, but last night, WBA stock was up by 0.26% possibly due to market factors, investor sentiment, or other positive developments.
- The article discusses Walgreens Boots Alliance (WBA) stock, which was up by 0.26% last night, and notes that the stock went up due to Super Micro Computer (SMCI) replacing WBA in the Nasdaq-100, a growth-focused index heavily weighted toward the technology sector.
- The article outlines high-yield stocks from the Dow Jones Industrial Average, including Walgreens Boots Alliance (WBA), which saw a 0.26% increase in its stock price. The rise in WBA stock can be attributed to its compelling financial foundation, attractive dividend yield of 8.9%, strong balance sheet, operational strength, strategic initiatives aimed at growth, and consistent commitment to returning value to shareholders, making it an appealing choice for investors seeking reliable income and potential capital appreciation.
- The article discusses how Walgreens Boots Alliance (WBA) stock went up by 0.26% last night, and the reason for this increase is not directly specified in the provided excerpt.
|
| 2024-07-15 | +1.74 % |
|
| 2024-07-12 | +0.61 % |
|
| 2024-07-10 | +4.36 % |
|
| 2024-07-09 | -0.28 % |
- The article investigates potential claims on behalf of Walgreens Boots Alliance, Inc. (WBA) investors following the company's earnings report on June 27, 2024, where the earnings guidance for the full year was lowered, leading to a stock drop of over 22%, which likely contributed to the 0.28% decline in WBA's stock price last night.
- The article discusses the outlook on CVS Health stock by TD Cowen, citing factors impacting its second-quarter performance that could be below consensus expectations, and Walgreens Boots Alliance (WBA) stock going down after its fiscal third-quarter 2024 earnings fell short of expectations and a downward revision in its adjusted earnings per share guidance, potentially influenced by various market factors such as the opioid crisis litigation, competition in the pharmaceutical sector, and challenges faced by CVS Health.
- The Walgreens Boots Alliance (WBA) stock was down by -0.28% last night as the company plans long-term changes to recover from a disappointing quarter by trimming its investment in the VillageMD clinic chain following losses, and the stock market's rally may have been driven by the expectation of a rate cut that could benefit the overall economy but may not immediately impact ordinary consumers who are facing challenges like inflation and higher food costs.
|
| 2024-07-08 | -3.91 % |
|
| 2024-07-03 | -4.06 % |
|
| 2024-07-02 | -0.09 % |
|
| 2024-07-01 | -4.3 % |
- Summary: Boots' managing director Sebastian James is leaving Walgreens Boots Alliance for a new role in healthcare, as the parent company shifts focus away from retail, causing the stock to drop by -4.3% due to failed sale attempts and the company's redirection towards the U.S. healthcare sector.
Reasons for Walgreens Boots Alliance (WBA) stock going down: The stock went down due to the company's failed attempt to sell the British beauty and pharmacy chain Boots, signaling a shift away from retail towards the U.S. healthcare sector, leading to uncertainty and a lack of interest from potential buyers for the retail division, ultimately impacting the stock price negatively.
- Summary: Walgreens Boots Alliance (WBA) stock experienced a significant 54% loss, marking it as the worst-performing S&P 500 stock in the first half of 2024, with the stock down by 4.3% last night. The decline in WBA stock can be attributed to challenges in the U.S. retail environment, declining reimbursement rates for prescription drugs, profitability issues in the pharmacy industry, reduction in earnings guidance, and plans to potentially close underperforming stores.
Reasons for Walgreens Boots Alliance (WBA) stock decline: Challenges in the U.S. retail environment, declining reimbursement rates for prescription drugs, profitability issues in the pharmacy industry, reduction in earnings guidance, and potential closure of underperforming stores.
|
| 2024-06-28 | -0.78 % |
- The article discusses Walgreens Boots Alliance (WBA) as a global leader in integrated healthcare, pharmacy, and retail, where its stock recently dropped by -0.78%, reportedly due to concerns regarding its third-quarter earnings report and uncertainties around navigating a challenging market environment.
- The article discusses how Mizuho Securities reduced its outlook on Walgreens Boots Alliance (WBA) stock due to challenges faced in the retail pharmacy sector, leading to a -0.78% decrease in stock value; the revision followed the company's fiscal third quarter earnings release which highlighted difficulties in the retail pharmacy market and the company's strategic review to address these issues, while also noting improvements in its International and U.S. Healthcare segments, although a full recovery in the core U.S. segment may be a longer-term possibility, causing Mizuho to maintain a Neutral rating on the stock.
- Summary: Economists and market experts are welcoming the latest key piece of inflation data, which shows the Personal Consumption Expenditure (PCE) price index dropping to a 2.6% year-on-year rate in May 2024, signaling progress in the Federal Reserve's efforts to bring inflation closer to its 2% target and leading to predictions of interest rate cuts by year-end.
Answer: Walgreens Boots Alliance (WBA) stock went down due to market experts questioning the perceived strength of the consumer market and citing disappointing reports from consumer discretionary companies, which suggests that the real-world consumer spending may not be aligning with Wall Street's expectations.
- The article discusses a few key updates from the stock market, including a slight increase in S&P 500 and Nasdaq Composite, a new low-cost fashion service being planned by Amazon to compete with companies like Shein and Temu, and disappointing earnings and lowered guidance from Walgreens Boots Alliance resulting in a 22% stock decline, with potential factors being uncertainty about consumer spending and revenue softness in China leading to the stock downturn.
|
| 2024-06-27 | -22.16 % |
|
| 2024-06-24 | -0.38 % |
|
| 2024-06-18 | +6.34 % |
|
| 2024-06-11 | -0.06 % |
|
| 2024-06-10 | +0.63 % |
|
| 2024-06-07 | -0.13 % |
|
| 2024-06-06 | -0.5 % |
|
| 2024-06-05 | -1.06 % |
|
| 2024-06-04 | +1.19 % |
|
| 2024-06-03 | -1.85 % |
|
| 2024-05-31 | +5.39 % |
|
| 2024-05-28 | -4.05 % |
- The article mentions that Walgreens Boots Alliance (WBA) stock was down by 4.05% last night, possibly due to concerns about the stock market being overbought after the S&P 500 index's significant climb, indicating value-conscious investors may be hesitant to purchase stocks, including WBA.
- Walgreens Boots Alliance (WBA) stock was down by 4.05% last night, and the reason for the decrease may be due to the announcement of their first community health fair in San Juan, which included health-related education, screenings, and vaccinations, showcasing their commitment to healthcare services and community engagement.
- The article discusses the decline in Walgreens Boots Alliance (WBA) stock, which has dropped over 45% in the past year and over 75% in the past decade, attributing the decrease to various factors affecting the company's performance, such as challenges within the US healthcare system, competition from other healthcare players like Rite Aid and Express Scripts, and the leadership changes with new figures like Rosalind Brewer and Tim Wentworth.
- The article highlights the decline in stock prices of well-known companies such as Walgreens Boots Alliance (WBA), which has experienced a -4.05% decrease in its stock value, with factors unique to each company contributing to the downward trend. Walgreens Boots Alliance's stock decline can be attributed to various factors, such as a 19.16% drop in earnings this year and the company's debt-to-equity ratio of 2.57, along with a dividend payout of 9.33%.
|
| 2024-05-23 | -3.16 % |
- The Walgreens Boots Alliance stock fell by -3.16% as drug wholesaler Cencora agreed to buy about $400 million in stock back from Walgreens Boots Alliance, leading to the stock hitting its lowest level since 1998.
- The article reports that Walgreens Boots Alliance (WBA) has sold more shares of drug distributor AmerisourceBergen, now known as Cencora, for approximately $400 million to use for debt reduction and general corporate purposes, leading to a 3.16% drop in the stock price; the stock went down due to the sale of shares to raise money for debt reduction and other corporate purposes.
- The Walgreens Boots Alliance (WBA) stock experienced a 3.16% decline last night, currently trading at $17 per share and approximately 70% below its April 2021 levels due to slowing sales growth, weakening consumer spending, opioid-related settlements, VillageMD acquisition charges, while also facing challenges such as high debt levels and weak consumer demand.
- The article discusses the recent decrease in Walgreens Boots Alliance (WBA) stock by -3.16% due to the pharmacy chain's decision to cut its dividend for the first time in nearly 50 years in response to declining sales and increased competition, aiming to save $800 million this year.
|
| 2024-05-22 | -1.26 % |
|
| 2024-05-21 | -6.4 % |
|
| 2024-05-20 | -1.98 % |
|
